ArticleTranslational lung cancer research2021
The clinical benefit of molecular re-assessments in management of progressive lung cancer.
Carina Wenzel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it